2m 2m 2m 2m 2m 2m 2m
BRIDGEBIO PHARMA (BBIO)
NASDAQ
$83.76+$0.68 (+0.82%)
Price as of Jul 14, 2026 4:03 AM EDT- $16.8BMarket Cap
- 74.21%1-Year Change
- BiotechnologyIndustry
BRIDGEBIO PHARMA (BBIO)
$83.76+$0.68 (+0.82%)
BBIO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $83.08 | ||
Change | -$2.81 (-3.27%) | ||
Open | $84.84 | ||
High | $85.38 | ||
Low | $81.37 | ||
Previous Close | $85.89 | ||
Volume | 3,430,110 | ||
30-Day Average Volume | 5,339,789 | ||
1-Week Change | 6.86% | ||
1-Month Change | 24.37% | ||
1-Year Change | 74.21% | ||
3-Year Change | 379.95% | ||
5-Year Change | 32.44% | ||
Fundamentals | |||
Shares Outstanding | 195.9M | ||
Total Assets | $1.4B | ||
Market Cap | $16.8B | ||
Enterprise Value | $17.1B | ||
Period: QTR TTM FY | |||
Revenue | $180.6M | ||
Net Income | -$166.6M | ||
Free Cash Flow | -$197.3M | ||
EBIT | -$165.3M | ||
EBITDA | -$164.1M | ||
Net Working Capital | $424.9M | ||
EPS | -$0.84 | ||
Enterprise Value/EBITDA | -104 | ||
Enterprise Value/Revenue | 95 | ||
P/B | -7 | ||
P/E | -102 | ||
PEG | -6 | ||
Price/Free Cash Flow | -85 | ||
Price/Operating Cash Flow | -85 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue